Spinal epidural lipomatosis (SEL) is an overgrowth of fat tissue in the spinal canal that can press on the spinal cord or nearby nerves, producing back pain, leg symptoms, and in severe cases, serious neurological problems. It is found on roughly 2.5% of spinal MRIs, though only a small fraction of those cases cause significant symptoms. The condition is most closely tied to obesity and long-term steroid use, and treatment ranges from weight loss to surgery depending on how much nerve compression is involved.
What Happens in the Spine
A thin layer of fat normally sits in the epidural space, the area between the bony spinal canal and the protective sac (the dural sac) that surrounds the spinal cord and nerve roots. This fat acts as a cushion. In SEL, that fat layer grows far beyond its normal size. The excess tissue takes up room that the spinal cord and nerves need, gradually squeezing them. Because the spinal canal is a fixed bony tube, there is nowhere for the extra tissue to go except inward, against the neural structures.
The overgrowth tends to collect most heavily along the back (dorsal) side of the spinal canal, and it favors the lower thoracic and lumbar spine, though it can appear at any level. The fat is unencapsulated, meaning it is not contained in a neat pocket like a lipoma. Instead, it infiltrates diffusely through the epidural space.
Symptoms and How They Progress
Many people with mild epidural fat overgrowth have no symptoms at all. When the condition does cause trouble, the symptoms depend on where the compression occurs and how severe it is. Patients with symptomatic SEL can present with radiculopathy (shooting pain along a nerve), myelopathy (spinal cord dysfunction causing weakness or coordination problems), claudication (leg pain or heaviness with walking), cauda equina syndrome, or in extreme cases paraplegia.1PubMed Central. Spinal Epidural Lipomatosis: A Review of Pathogenesis, Characteristics, Clinical Presentation, and Management
The most common early complaint is low back pain, sometimes accompanied by leg pain that worsens with standing or walking and improves with sitting or bending forward. This pattern closely mimics ordinary lumbar spinal stenosis, which is one reason SEL often goes unrecognized initially. Numbness or tingling in the legs, difficulty with balance, and changes in bladder or bowel function are red flags that compression is becoming severe. Because symptoms tend to build slowly over months or years, patients sometimes attribute them to aging or weight gain and delay seeking care.
The Two Big Drivers
Two factors dominate the list of known causes: excess body weight and corticosteroid exposure. Understanding which one (or both) applies to a given patient shapes the entire treatment plan.
Obesity
Obesity is the most common cause of SEL that is unrelated to steroid use, accounting for roughly a quarter of cases in published reviews.2PubMed Central. Spinal Epidural Lipomatosis: A Comprehensive Review The connection is not just that heavier people carry more fat everywhere. Research has found that inflammatory signals are significantly elevated in obese patients with SEL, which likely drives fat cells in the epidural space to enlarge beyond what simple weight gain alone would explain.2PubMed Central. Spinal Epidural Lipomatosis: A Comprehensive Review A longitudinal imaging study confirmed that epidural fat volume tracks with body mass index, with each one-point rise in BMI corresponding to a measurable increase in dorsal epidural fat.3Clinical Imaging. Correlation of spinal epidural fat volume with body mass index: a longitudinal study
In a case-control study, patients who had epidural lipomatosis had an average BMI of about 36, compared to roughly 29 in matched controls. The probability of developing the condition rose in a linear fashion up to a BMI of about 35, after which it plateaued. The same study found that triglyceride levels were significantly higher in the SEL group.4PubMed Central. Multiple epidural steroid injections and body mass index linked with occurrence of epidural lipomatosis: a case series
Corticosteroids
Long-term steroid therapy is the other major culprit. Steroids activate receptors on fat cells and promote fat deposition in specific body regions, including the epidural space. Chronic use can cause the epidural fat to enlarge enough to compress neural structures.5PubMed Central. Chronic Steroid Use Causing Spinal Epidural Lipomatosis This is the same mechanism behind the characteristic fat redistribution seen in Cushing’s syndrome, where fat accumulates in the face, upper back, and trunk. SEL has been documented in cardiac transplant patients on chronic immunosuppressive steroids, in people with autoimmune diseases requiring prolonged courses, and in children being treated for leukemia and lymphoma.6PubMed. Symptomatic spinal epidural lipomatosis as a complication of steroid immunosuppression in cardiac transplant patients
A smaller number of cases are labeled idiopathic, meaning no clear cause is identified. Some patients develop SEL after spinal surgery, likely because local tissue changes and scarring alter how fat distributes in the epidural space.
How Common Is It
A large imaging study of nearly 29,000 patients who had spinal MRIs found an overall SEL prevalence of about 2.5%. Most of those cases were incidental findings or accompanied by general spinal symptoms that could have other explanations. Truly symptomatic SEL, where the fat overgrowth was clearly the cause of the patient’s neurological complaints, was identified in only about 0.1% of scans.7PubMed. The prevalence of spinal epidural lipomatosis on magnetic resonance imaging Risk factors associated with SEL in that population included older age, male sex, higher comorbidity burden, and prior epidural steroid injections.
These numbers mean that most people with some degree of epidural fat overgrowth will never know they have it. The condition sits on a spectrum, from trivially increased fat that shows up incidentally on an MRI done for other reasons, all the way to severe compression that needs surgery.
Diagnosis and MRI Grading
MRI is the standard way to diagnose SEL. On an MRI, epidural fat lights up brightly on certain sequences, making it easy to see how much space it occupies relative to the dural sac. A grading system developed from a study of over 2,500 patients classifies the condition into four levels based on how much of the spinal canal is occupied by fat. About 79% of scanned patients fell into the normal category, roughly 12% had mild overgrowth, about 7% had moderate overgrowth, and about 2% had severe overgrowth where fat occupied three-quarters or more of the canal space.8PubMed. Lumbosacral epidural lipomatosis: MRI grading
This grading system helps guide treatment decisions. A patient with grade I findings and mild back pain will be managed very differently from someone with grade III compression and progressive weakness. Plain X-rays and CT scans can show spinal narrowing but are far less reliable than MRI for distinguishing fat from other soft tissue causes of compression.
Conservative Treatment
For patients whose SEL is linked to excess weight, losing weight is the first and most important step. Because epidural fat volume tracks directly with BMI, meaningful weight loss can shrink the fat enough to relieve nerve compression. In a published case, a patient who lost 53 pounds through medically supervised weight management reported complete resolution of pain.9PubMed Central. Significant symptom resolution of spinal lipomatosis with weight loss Another case demonstrated not only symptom improvement but actual radiographic improvement on follow-up MRI after dietary weight loss alone.10PubMed Central. Epidural Lipomatosis and Associated Spinal Stenosis-The Impact of Weight Loss: A Case Report
For steroid-induced SEL, reducing or tapering the steroid dose is the corresponding first-line approach. In early cases, especially when steroids can be safely decreased, the epidural fat may shrink on its own over weeks to months.11Neurospine. Steroid-induced Spinal Epidural Lipomatosis after Suprasella Tumor Resection – Section: DISCUSSION The challenge, of course, is that many patients need steroids for serious underlying conditions like organ transplant rejection, autoimmune disease, or cancer. In those situations, physicians have to weigh the risk of the original disease flaring against the benefit of reducing spinal compression. Switching to a steroid-sparing medication, when one is available, can sometimes thread this needle.
Physical therapy, anti-inflammatory medications, and activity modification can help manage symptoms while weight loss or steroid tapering takes effect, but these measures treat symptoms without addressing the underlying fat overgrowth.
When Surgery Becomes Necessary
Surgery is reserved for patients who have severe or progressive neurological deficits, those who fail conservative treatment, or people whose compression is too advanced for weight loss alone to solve. The standard approach is a laminectomy, where a surgeon removes part of the bony arch of one or more vertebrae to access and debulk the overgrown fat. In a study of 22 patients who underwent surgical decompression for lumbar SEL, half experienced a clinically meaningful improvement in their overall symptom scores within three months. About three-quarters reported reduced leg pain, and these improvements held up at two years of follow-up.12PubMed. Patient-reported outcome of surgical treatment for lumbar spinal epidural lipomatosis
Minimally invasive techniques are gaining traction. Endoscopic approaches, where a small camera and instruments are inserted through a tiny incision, have shown promising results in individual cases, with patients experiencing resolution of symptoms and normalization of neurological deficits.13PubMed. Minimally invasive excision of lumbar epidural lipomatosis using a spinal endoscope A newer technique using two small portals for the endoscope and instruments achieved nerve decompression by directly removing excess fat while preserving the surrounding muscles, and all three patients in an early case series had reduced pain and improved function without complications or spinal instability.14PubMed Central. Technical description and clinical evaluation of three cases of unilateral biportal endoscopic decompression for symptomatic spinal epidural lipomatosis
For patients with extensive disease spanning many spinal levels, a modified approach using several small incisions instead of one long one has been described. This strategy reduces the length of any single wound, which matters for patients with obesity, diabetes, or other conditions where healing is a concern and blood loss needs to be minimized.15PubMed. Extensive Symptomatic Thoracolumbar Epidural Lipomatosis Treated With Minimally Invasive Hemilaminectomies: Technical Case Report
The Epidural Steroid Injection Dilemma
Here is where things get genuinely tricky for both patients and doctors. Epidural steroid injections (ESIs) are among the most common procedures in pain management, used to calm inflamed nerves in the spine. But if a patient already has SEL, or is at risk for it, injecting more steroid directly into the epidural space raises an obvious concern: could you be feeding the problem?
The evidence suggests the concern is warranted, though the picture is not entirely clear-cut. A review of available data found low-level evidence of an association between ESIs and the development or worsening of SEL, with prior ESI emerging as the strongest risk factor for SEL in one multivariate analysis (roughly 3.5 times the odds compared to patients without prior injections). After three or more injections, the probability of radiographic evidence of SEL climbed steeply, reaching nearly 100% after four injections in one study.16Interventional Pain Medicine. Preventing procedure-related complications: Epidural lipomatosis and postpartum steroid exposure
At the same time, small case series have reported that ESIs can actually help certain SEL patients’ pain in the short term, with some patients seeing substantial pain relief at two weeks without worsening neurological exams over follow-up periods of several months. Two other case series reported the opposite: neurological worsening within months of ESI. One extreme case involved a patient who received over 100 epidural steroid injections across 12 years and developed sudden paralysis from spinal cord compression requiring emergency surgery.16Interventional Pain Medicine. Preventing procedure-related complications: Epidural lipomatosis and postpartum steroid exposure
The practical takeaway is that if you have known SEL or significant risk factors for it, your doctor should think carefully before recommending repeated epidural steroid injections. A single injection may be low risk, but the evidence strongly suggests that cumulative exposure compounds the problem. This is a conversation worth having explicitly with your pain management physician.
SEL in Children and Adolescents
SEL is overwhelmingly an adult condition, but it does occur in children, almost always in the context of steroid treatment for another disease. Pediatric cases have been documented in children with leukemia, lymphoma, and chronic autoimmune conditions who require prolonged courses of glucocorticoids.17PubMed Central. Spinal epidural lipomatosis in a pediatric patient with a malignant brain tumor: illustrative case
In a review of 14 pediatric cases at a single institution, all patients with leukemia or lymphoma who developed SEL had received systemic or intrathecal corticosteroids. The condition was often discovered when lumbar punctures (needed for chemotherapy delivery) became unexpectedly difficult. Older age and higher BMI were risk factors even within this pediatric population. Most of these children completed their chemotherapy without needing surgery, though several required placement of an alternative access device for delivering medication to the central nervous system.18PubMed Central. Spinal epidural lipomatosis in children with hematologic malignancies
An analysis of pediatric cases from the literature found that symptoms typically appeared about 1.3 years after starting steroid therapy, though the range spanned from just 3 months to over 6 years. Back pain was the most common complaint. Encouragingly, the condition frequently improved when the steroid dose was reduced.19PubMed. Steroid-induced spinal epidural lipomatosis in pediatric patients For parents of children on long-term steroids, new or unexplained back pain deserves attention and possibly imaging, especially if the child also develops difficulty walking or changes in bladder habits.
Why SEL Gets Misdiagnosed
One of the frustrating realities of SEL is how easily it masquerades as more common spinal conditions. The leg pain and walking difficulty it produces look almost identical to degenerative lumbar stenosis, which is vastly more common and tends to affect the same demographic: older adults who are overweight. A patient who walks into a spine clinic with these complaints will usually be evaluated for disc herniation, bone spurs, or ligament thickening long before anyone considers fat overgrowth as the culprit.
Even on MRI, SEL can be overlooked if the radiologist is focused on disc pathology and does not specifically assess the epidural fat. Awareness of the condition has grown over the past decade, but it remains underdiagnosed. A clue that fat might be the problem rather than (or in addition to) the usual degenerative suspects is when the degree of bony stenosis on imaging seems too mild to explain the patient’s symptoms, or when symptoms progress despite treatment directed at disc or joint disease. If you have been told your MRI “doesn’t really explain” your leg pain, and you carry excess weight or take steroids, it is worth asking whether epidural fat was evaluated.
Recurrence After Treatment
SEL can come back. If the underlying driver persists, so does the risk. A patient who loses weight and sees symptom improvement but then regains the weight may see the fat reaccumulate. Similarly, someone whose steroid-induced SEL resolves after dose reduction but who later needs higher doses for a disease flare can develop the condition again. Even after surgical debulking, recurrence has been reported when patients remain obese or continue on steroids.
This makes ongoing management of body weight and steroid exposure genuinely important, not just for the initial treatment but for the long term. For patients who cannot avoid steroids, using the lowest effective dose and exploring steroid-sparing alternatives wherever possible reduces recurrence risk. For patients whose primary driver is obesity, the condition provides one more reason, beyond the many already known, that sustained weight management matters for spinal health. Bariatric surgery has been used in some severe cases as an indirect treatment for SEL, though formal studies of this approach are lacking.